COVID-19 Whole-Genome Resequencing with Redundant Tiling PCR and Subtract-Based Amplicon Normalization Successfully Characterized SARS-CoV-2 Variants in Clinical Specimens.

Tatsuki Sugi, Mizanur Rahman, Rummana Rahim, Abu Hasan, Naoko Kawai, Kyoko Hayashida, Junya Yamagishi
Author Information
  1. Tatsuki Sugi: Division of Collaboration and Education, International Institute for Zoonosis Control, Hokkaido University, Nishi10-Kita20, Sapporo, Japan.
  2. Mizanur Rahman: Evercare Hospital Dhaka, Bashundhara R/A, Block-E, Plot-81, Dhaka-1229, Dhaka, Bangladesh. ORCID
  3. Rummana Rahim: Evercare Hospital Dhaka, Bashundhara R/A, Block-E, Plot-81, Dhaka-1229, Dhaka, Bangladesh.
  4. Abu Hasan: Evercare Hospital Dhaka, Bashundhara R/A, Block-E, Plot-81, Dhaka-1229, Dhaka, Bangladesh.
  5. Naoko Kawai: Division of Collaboration and Education, International Institute for Zoonosis Control, Hokkaido University, Nishi10-Kita20, Sapporo, Japan.
  6. Kyoko Hayashida: Division of Collaboration and Education, International Institute for Zoonosis Control, Hokkaido University, Nishi10-Kita20, Sapporo, Japan.
  7. Junya Yamagishi: Division of Collaboration and Education, International Institute for Zoonosis Control, Hokkaido University, Nishi10-Kita20, Sapporo, Japan. ORCID

Abstract

With an increasing number of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) sequences gathered worldwide, we recognize that deletion mutants and nucleotide substitutions that may affect whole-genome sequencing are accumulating. Here, we propose an additional strategy for tiling PCR for whole-genome resequencing, which can make the pipeline robust for mutations at the primer annealing site by a redundant amplicon scheme. We further demonstrated that subtracting overrepresented amplicons from the multiplex PCR products reduced the bias of the next-generation sequencing (NGS) library, resulting in decreasing required sequencing reads per sample. We applied this sequencing strategy to clinical specimens collected in Bangladesh. More than 80% out of the 304 samples were successfully sequenced. Less than 5% were ambiguous nucleotides, and several known variants were detected. With the additional strategies presented here, we believe that whole-genome resequencing of SARS-CoV-2 from clinical samples can be optimized.

References

  1. PLoS One. 2021 Oct 29;16(10):e0259277 [PMID: 34714886]
  2. Nat Med. 2020 Sep;26(9):1405-1410 [PMID: 32678356]
  3. Proc Natl Acad Sci U S A. 2020 Mar 31;117(13):7001-7003 [PMID: 32165541]
  4. Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9241-9243 [PMID: 32269081]
  5. Bioinformatics. 2018 Dec 1;34(23):4121-4123 [PMID: 29790939]
  6. Nat Med. 2021 Sep;27(9):1518-1524 [PMID: 34504335]
  7. J Clin Microbiol. 2021 Oct 19;59(11):e0104621 [PMID: 34379527]
  8. Microbiol Spectr. 2021 Dec 22;9(3):e0180321 [PMID: 34878296]
  9. BMC Bioinformatics. 2019 May 10;20(1):236 [PMID: 31077131]
  10. Bioinformatics. 2021 Oct 08;: [PMID: 34623391]
  11. Bioinformatics. 2014 Aug 1;30(15):2114-20 [PMID: 24695404]
  12. China CDC Wkly. 2021 Dec 3;3(49):1049-1051 [PMID: 34934514]
  13. Virus Evol. 2021 Feb 04;7(1):veab006 [PMID: 33841912]
  14. J Med Virol. 2022 Jan;94(1):327-334 [PMID: 34524690]
  15. J Med Virol. 2022 Jan;94(1):310-317 [PMID: 34506640]
  16. PLoS One. 2016 Oct 5;11(10):e0163962 [PMID: 27706213]
  17. Sci Rep. 2021 Sep 7;11(1):17755 [PMID: 34493762]
  18. Sci Transl Med. 2022 Feb 23;14(633):eabk3445 [PMID: 35014856]
  19. Nat Biotechnol. 2011 Jan;29(1):24-6 [PMID: 21221095]
  20. Curr Protoc Bioinformatics. 2013;43:11.10.1-11.10.33 [PMID: 25431634]
  21. PLoS One. 2020 Sep 18;15(9):e0239403 [PMID: 32946527]
  22. Bioinformatics. 2009 Aug 15;25(16):2078-9 [PMID: 19505943]
  23. Genome Biol. 2019 Jan 8;20(1):8 [PMID: 30621750]
  24. J Clin Virol. 2022 Mar;148:105105 [PMID: 35220006]
  25. iScience. 2021 Aug 20;24(8):102892 [PMID: 34308277]
  26. Microbiol Resour Announc. 2021 Dec 9;10(49):e0076421 [PMID: 34881982]
  27. Brief Bioinform. 2022 Mar 10;23(2): [PMID: 35043153]

Word Cloud

Created with Highcharts 10.0.0sequencingSARS-CoV-2whole-genomePCRadditionalstrategyresequencingcanclinicalsamplesincreasingnumbersevereacuterespiratorysyndromecoronavirus-2sequencesgatheredworldwiderecognizedeletionmutantsnucleotidesubstitutionsmayaffectaccumulatingproposetilingmakepipelinerobustmutationsprimerannealingsiteredundantampliconschemedemonstratedsubtractingoverrepresentedampliconsmultiplexproductsreducedbiasnext-generationNGSlibraryresultingdecreasingrequiredreadspersampleappliedspecimenscollectedBangladesh80%304successfullysequencedLess5%ambiguousnucleotidesseveralknownvariantsdetectedstrategiespresentedbelieveoptimizedCOVID-19Whole-GenomeResequencingRedundantTilingSubtract-BasedAmpliconNormalizationSuccessfullyCharacterizedVariantsClinicalSpecimens

Similar Articles

Cited By

No available data.